Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

$3.79 Bn Musculoskeletal Pain Markets, 2019 - Insights, Epidemiology and Market Forecasts 2018-2028

DUBLIN, April 25, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019

Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019

BOCA RATON, Fla., April 25, 2019 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday,... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019

Amgen Announces Webcast of 2019 First Quarter Financial Results

THOUSAND OAKS, Calif., April 25, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Tuesday, April 30, 2019, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Amgen, Inc.

Global Bowel Management Systems Markets to 2023: C.R.Bard, Medtronic, and B.Braun Melsungen Contribute to North America's Dominance

DUBLIN, April 25, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2019

Omnicell Reports Results for First Quarter 2019

MOUNTAIN VIEW, Calif., April 25, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its first quarter ended March 31, 2019.

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2019

Zynex Schedules 2019 First Quarter Earnings

ENGLEWOOD, Colo., April 25, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Zynex Medical, Inc.

Kodiak Sciences Announces Presentations at ARVO 2019 Annual Meeting

PALO ALTO, Calif., April 25, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that presentations on its research will be made at the Association... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Kodiak Sciences Inc.

BioMarin Announces First Quarter 2019 Financial Results

SAN RAFAEL, Calif., April 25, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  BioMarin Pharmaceutical Inc.

Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland

GERMANTOWN, Md., April 25, 2019 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and a clinical stage biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Intrexon Corporation | Precigen, Inc.

AcelRx to announce first quarter 2019 results and provide an update on the company's business on Wednesday, May 8th, 2019

REDWOOD CITY, Calif., April 25, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release first quarter financial results after market close on Wednesday, May 8th, 2019. AcelRx management will host a live webcast... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  AcelRx Pharmaceuticals, Inc.

Stealth BioTherapeutics Completes Enrollment of Pivotal Study in Primary Mitochondrial Myopathy

BOSTON, April 25, 2019 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Stealth BioTherapeutics Inc.

Emily's Entourage Announces 4th Annual EENY: Ultra Violet

NEW YORK, April 25, 2019 /PRNewswire/ -- Emily's Entourage (EE), an innovative 501(C)3 foundation that has raised over $4... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019

Encompass Health reports results for first quarter 2019 and reiterates full-year 2019 guidance

BIRMINGHAM, Ala., April 25, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies, today reported... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Encompass Health Corp.

Diplomat Using SMRxT Technology to Enhance Patient Care

FLINT, Mich., April 25, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is expanding its strategic relationship with medication adherence company SMRxT, creator of the Nomi(®) system.

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Diplomat Pharmacy, Inc.

AlloSource Hosts 25th Anniversary Event Featuring Columbine Survivor And Tissue Recipient Kacey Ruegsegger Johnson

CENTENNIAL, Colo., April 25, 2019 /PRNewswire/ -- AlloSource┬«, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today celebrates 25 years of honoring donors and helping patients heal with an event featuring Columbine survivor and tissue... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  AlloSource

First-of-its-kind Commercial MicroED Solution Helps Researchers Quickly Resolve Organic and Inorganic Molecular Structures at Atomic Resolution

HILLSBORO, Ore., April 25, 2019 /PRNewswire/ -- Researchers and scientists analyzing crystallized protein samples in life sciences and materials research can now benefit from the first commercially released integrated solution for performing micro electron diffraction (MicroED), an advanced technique... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2019
Related companies:  Thermo Fisher Scientific Inc. | Dionex, Thermo Fisher Scientific | Thermo Fisher Scientific | Thermo Fisher Scientific

MyDx Announces 2018 Fiscal Year Results and Shareholder Update

Read more ››
By: Nasdaq / GlobenewsWire - 25 Apr 2019

Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline

Read more ››
By: Nasdaq / GlobenewsWire - 25 Apr 2019
Related companies:  Mateon Therapeutics, Inc

Stemline Therapeutics Announces New England Journal of Medicine Publication of ELZONRIS (tagraxofusp) Pivotal Study Results

Read more ››
By: Nasdaq / GlobenewsWire - 25 Apr 2019
Related companies:  Stemline Therapeutics, Inc.

Lexicon Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on May 1, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 25 Apr 2019
Related companies:  Lexicon Pharmaceuticals, Inc.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑